Aptamers for targeting coagulation factor XIII and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11421234
APP PUB NO 20210163945A1
SERIAL NO

16699742

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein is an aptamer specific to coagulation factor XIII (FXIII) and its uses thereof. Accordingly, the present aptamer is useful as a bio-tool to label thrombi, and/or as a targeting molecule to deliver drugs to thrombotic area. Therefore, the present disclosure also pertains to methods for treating diseases associated with FXIII, such as thrombosis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHANG GUNG UNIVERSITY259 WEN-HWA 1ST ROAD KWEI-SHAN TAO-YUAN 33302

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cheng, Kai-Wen Taoyuan, TW 102 473
Ma, Yunn-Hwa Taoyuan, TW 5 1
Tseng, Ching-Ping Taoyuan, TW 19 17

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Feb 23, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 23, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 23, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00